NCT01480115

Brief Summary

The ultrasound unit in Meir Medical Center developed new software to automated ovarian follicle count on the basis of 3D US. The investigators intent to evaluate this software at two steps:

  • To compared the abilities of the software to physician follicle count.
  • To evaluate with the software the antral follicle count, as expression to ovarian reserve at 3 different time of the month. The investigators believe that the software measurement of the small follicle can be better than the common antral follicle count that is use today, and by this accurate evaluation of the small follicle the investigators can evaluate the ovarian reserve at any time of the mount, and not only at the early follicular phase that use today.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 28, 2011

Completed
1.3 years until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

March 12, 2013

Status Verified

November 1, 2011

Enrollment Period

7 months

First QC Date

November 23, 2011

Last Update Submit

March 10, 2013

Conditions

Keywords

antral follicle countautomated antral follicle countovarian reserve

Outcome Measures

Primary Outcomes (1)

  • Antral follicle count accuracy during the menstrual cycle for ovarian reserve evaluation.

    Within the 28-35 days of the menstrual cycle.

Interventions

Ultrasound examination three times during the menstrual cycle to measure the AFC.

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study group will include women faced the fertility unit in Meir Medical Center. Each woman at her first evaluation will invite to volunteer. Also woman during a natural course treatment will invite to volunteer.

You may qualify if:

  • woman under age 40 years all
  • woman at evaluation before beginning of fertility treatment
  • woman with regular menstrual cycle

You may not qualify if:

  • woman who treat with ovulation induction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fertility unit, Meir Medical Center, Israel

Kfar Saba, Israel

Location

Related Publications (10)

  • Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005 Feb;83(2):291-301. doi: 10.1016/j.fertnstert.2004.10.011.

    PMID: 15705365BACKGROUND
  • Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril. 2007 Apr;87(4):764-75. doi: 10.1016/j.fertnstert.2006.11.006. Epub 2007 Jan 18.

    PMID: 17239869BACKGROUND
  • Raine-Fenning N, Jayaprakasan K, Clewes J. Automated follicle tracking facilitates standardization and may improve work flow. Ultrasound Obstet Gynecol. 2007 Dec;30(7):1015-8. doi: 10.1002/uog.5222. No abstract available.

    PMID: 18044823BACKGROUND
  • Styer AK, Toth TL. Antral follicle count in clinical practice: building the bridge from ovarian reserve to in vitro fertilization outcome. Fertil Steril. 2011 Feb;95(2):480-1; discussion 484-5. doi: 10.1016/j.fertnstert.2010.11.054. Epub 2010 Dec 23.

    PMID: 21183169BACKGROUND
  • Hsu A, Arny M, Knee AB, Bell C, Cook E, Novak AL, Grow DR. Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril. 2011 Feb;95(2):474-9. doi: 10.1016/j.fertnstert.2010.03.023.

    PMID: 20434151BACKGROUND
  • Olivennes F, Howies CM, Borini A, Germond M, Trew G, Wikland M, Zegers-Hochschild F, Saunders H, Alam V. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod Biomed Online. 2011 Feb;22 Suppl 1:S73-82. doi: 10.1016/S1472-6483(11)60012-6.

    PMID: 21575853BACKGROUND
  • Al-Azemi M, Killick SR, Duffy S, Pye C, Refaat B, Hill N, Ledger W. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum Reprod. 2011 Feb;26(2):414-22. doi: 10.1093/humrep/deq339. Epub 2010 Dec 8.

    PMID: 21147822BACKGROUND
  • Deb S, Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC. Ultrasound Obstet Gynecol. 2009 Apr;33(4):477-83. doi: 10.1002/uog.6310.

    PMID: 19212944BACKGROUND
  • Murtinger M, Aburumieh A, Rubner P, Eichel V, Zech MH, Zech NH. Improved monitoring of ovarian stimulation using 3D transvaginal ultrasound plus automated volume count. Reprod Biomed Online. 2009 Nov;19(5):695-9. doi: 10.1016/j.rbmo.2009.09.008.

    PMID: 20021717BACKGROUND
  • Raine-Fenning N, Jayaprakasan K, Deb S, Clewes J, Joergner I, Dehghani Bonaki S, Johnson I. Automated follicle tracking improves measurement reliability in patients undergoing ovarian stimulation. Reprod Biomed Online. 2009 May;18(5):658-63. doi: 10.1016/s1472-6483(10)60010-7.

    PMID: 19549444BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood and serum for FSH, LH, E2, AMH, Prolactin, TSH, Testosterone, Progesterone, 17-OHP, DHEA-S.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Roni Tepper, professor

    Meir Medical Center Israel

    STUDY DIRECTOR

Central Study Contacts

Roni Tepper, professor

CONTACT

Merav Sharvit, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2011

First Posted

November 28, 2011

Study Start

April 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

March 12, 2013

Record last verified: 2011-11

Locations